Comparative clinical and functional outcomes of implantation of «reverse-M» and «reverse-M1» IOL in patients with high myopia in the long-term postoperative period

The formation of secondary cataracts in patients with high myopia remains the main cause of vision loss in the long-term postoperative period. In view of that fact, the Fyodorov Eye Microsurgery Federal State Institution has developed a soft model of posterior chamber “reverse” IOL, which allows reducing the development of secondary cat aracts.Purpose. Comparative analysis the clinical and functional outcomes of «reverse-M» and «reverse-M1» IOL implantation in patients with high myopia in the long-term postoperative period.Material and methods. Clinical research has been carried out on 140 eyes of 97 patients with high myopia aged from 42 to 83 years (on average, 64.24±0.79 years) after phacoemulsification with IOL implantation in high myopia. The main group consisted of 57 eyes of 40 patients who were implanted with «reverse-M1» IOL, the control group consisted of 83 eyes of 57 patients who were implanted with “reverse-M” IOL. Before the surgery, the uncorrected visual acuity in any patient did not exceed 0.01, and the best corrected visual acuity was no more than 0.2 (80%). The follow-up period was up to 5 years.Results. Visual functions in most patients increased and remained stable throughout the postoperative period, amounting to 0.55±0.04 in the main group, and 0.54±0.03 in the control group. In the late postoperative period, dissection of the posterior lens capsule with «reverse-M» IOL was performed in 11 eyes of 13 patients (13.2%). In the main group, YAG laser dissection of the posterior capsule was required in 2 patients with 3 eyes (5.3%).Conclusion. «Reverse-M1» IOL implantation is safe, predictable and allows to reduce the incidence of secondary cataracts by more than 2 times in comparison with the «reverse-M» IOL.